Results 211 to 220 of about 92,035 (255)
Some of the next articles are maybe not open access.
Histocompatibility (HLA) Antigens in Keratoconus
American journal of optometry and physiological optic, 1984ABSTRACT To determine if susceptibility to keratoconus is associated with the histocompatibility (HLA) system, we HLA‐typed 39 keratoconic patients and 208 normal controls for 63 HLA‐A, ‐B, and ‐C antigens. The antigen frequencies for the keratoconic patients did not differ significantly from the frequencies for the control patients ...
P J, McKinney, D P, Yolton
openaire +2 more sources
Histocompatibility antigens in Parkinson's disease
Acta Neurologica Scandinavica, 2009The possible association of 7 HLA specificities in the HLA-A locus and 16 specificities in the HLA-B locus with susceptibility to Parkinsonian syndrome was investigated in a total of 36 patients with paralysis agitans (PA), as well as in 11 patients with other Parkinsonian syndromes, and 176 controls in Japan. There was no clear association between HLA-
S, Takagi, Y, Shinohara, K, Tsuji
openaire +2 more sources
2014
Human Leukocyte Antigen (HLA) is under the control of a gene region, which is called Major Histocompatibility Complex (MHC) Gene Region. This region consists of three main groups which are the MHC Class I (HLA-I, -B, -C, -E, -F, -G), MHC Class II (HLA-DR, -DP, -DQ, -DO, DN) and MHC Class III (C2, C4A, C4B, PF, TNF- a, b) antigens.
openaire +3 more sources
Human Leukocyte Antigen (HLA) is under the control of a gene region, which is called Major Histocompatibility Complex (MHC) Gene Region. This region consists of three main groups which are the MHC Class I (HLA-I, -B, -C, -E, -F, -G), MHC Class II (HLA-DR, -DP, -DQ, -DO, DN) and MHC Class III (C2, C4A, C4B, PF, TNF- a, b) antigens.
openaire +3 more sources
The immunogenomics of minor histocompatibility antigens
Immunological Reviews, 2002Summary: Minor histocompatibility (H) antigens are a diverse assemblage of major histocompatibility complex (MHC)‐bound peptides with the unifying property of acting as alloantigens that induce allogeneic tissue rejection. They are a consequence of any form of accumulated genetic variation that translates to differential MHC‐presented peptide epitopes,
Roopenian, D, Choi, E Y, Brown, A
openaire +3 more sources
Histocompatibility (Hla) Antigens and Keratoplasty
American Journal of Ophthalmology, 1978In 84 cases of keratoplasty, all patients had densely vascularized corneas and a history of prior exposure to HLA antigens by pregnancy, blood transfusion, or previous transplantation. Donors were selected on the basis of a negative crossmatch to avoid donor antigens to which the recipient was preimmunized.
W J, Stark +3 more
openaire +2 more sources
Australian and New Zealand Journal of Obstetrics and Gynaecology, 1983
Daunter B., Mackay E.V.
openaire +4 more sources
Daunter B., Mackay E.V.
openaire +4 more sources
Minor Histocompatibility Antigens in GVL
2000In syngeneic bone marrow transplantation (BMT) and in recipients of autologous BMT, relapse rates are high. No MHC or minor histocompatibility antigen (mHag) disparities exist and thus no alloreactivities can be induced. This is clearly different in allogeneic BMT, where the relapse rates are significantly lower and a relationship is seen between the ...
Mutis, Tuna, Goulmy, Els
openaire +3 more sources
Histocompatibility antigens in varicocele
Tissue Antigens, 1982D P, Sengar, H, Mervart, R W, Hudson
openaire +2 more sources

